Mechanisms of action of endocrine treatment in breast cancer

Related Experiment Video

Updated: Oct 2, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

E Lønning1, E A Lien

  • 1Department of Oncology, Haukeland University Hospital, Bergen, Norway.

Critical Reviews in Oncology/Hematology
|November 1, 1995
PubMed

Insights

Exploring novel endocrine therapies for breast cancer is crucial. Understanding drug resistance mechanisms and evaluating new treatment combinations, including growth factor alterations, can improve patient outcomes.

Area of Science:

  • Oncology
  • Endocrinology
  • Pharmacology

Background:

  • Endocrine therapy is a cornerstone in breast cancer treatment.
  • While basic mechanisms are understood, additional factors influence drug action and resistance.
  • Novel endocrine drugs are emerging, necessitating further research into their efficacy and resistance patterns.

Purpose of the Study:

  • To investigate the mechanisms of action and resistance of endocrine therapies in breast cancer.
  • To explore the potential of novel antiestrogens and aromatase inhibitors.
  • To assess the role of biochemical parameters like growth factors in treatment response and resistance.

Main Methods:

  • Analysis of cross-resistance patterns between steroidal and non-steroidal antiestrogens.
  • Evaluation of sequential or combined use of different aromatase inhibitors.
  • Monitoring of biochemical parameters, including growth factors, during endocrine treatment.

Main Results:

  • Findings on cross-resistance can elucidate drug mechanisms.
  • Combining endocrine treatments may offer synergistic effects.
  • Tracking biochemical alterations can reveal insights into drug resistance development.

Conclusions:

  • Further research into novel endocrine drugs and combinations is warranted.
  • Understanding resistance mechanisms is key to optimizing breast cancer therapy.
  • Monitoring biochemical markers can guide treatment strategies and predict resistance.

More Related Videos

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Endocrine Signaling01:52

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
Endocrine Signaling01:52

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...